Academic Bibliography

Search 200 years of publications by Ghent University researchers.

prof. Sylvie Rottey

Work address: C. Heymanslaan 10, ingang 12 - verdieping 2
9000 Gent
Email: Sylvie.Rottey@UGent.be
ORCID iD: 0000-0003-2060-3725

Show Sort by

Add to list
- Journal Article
Managing viral hepatitis in cancer patients under immune checkpoint inhibitors: should we take the risk?

Stijn J De Keukeleire, Tijl Vermassen, Zahra M Nezhad, Tessa Kerre (UGent) , Vibeke Kruse (UGent) , Hans Van Vlierberghe (UGent) , Karim Vermaelen (UGent) and Sylvie Rottey (UGent)

(2021) Immunotherapy.
Add to list
- Journal Article
- A1
- open access
Impact of solid cancer on in-hospital mortality overall and among different subgroups of patients with COVID-19 : a nationwide, population-based analysis

Evandro de Azambuja, Mariana Brandao, Hans Wildiers, Annouschka Laenen, Sandrine Aspeslagh, Christel Fontaine, Joelle Collignon, Willem Lybaert, Jolanda Verheezen, Annemie Rutten, et al.

(2020) ESMO OPEN. 5(5).
Add to list
A randomized phase II study of Nivolumab plus Ipilimumab versus standard of care in previously untreated and advanced non-clear cell renal cell carcinoma (Suniforecast)

Marit Ahrens, Bernard Escudier, Ekaterini Boleti, Marc-Oliver Grimm, Marine Gross Goupir, Pilippe Barthelemy, Gwenaelle Gravis, Jens Bedekes, Philipp Ivanyi, Andrej Panic, et al.

(2020) ONCOLOGY RESEARCH AND TREATMENT. 43(15 (Suppl. 1)). p.226-226
Add to list
'In-house' data on the outside : a mobile health approach

Qinlei Huang, Tami Crumley, Christina Walters, Liesbeth Cluckers, Ingeborg Heirman, Radha Railkar, Gaurav Bhatia, Matthew Cantor, Christopher Benko, Elena S Izmailova, et al.

(2020) CLINICAL PHARMACOLOGY & THERAPEUTICS. 107(4). p.948-956
Add to list
Targeting FGFR in bladder cancer : ready for clinical practice?

Stijn De Keukeleire (UGent) , Daan De Maeseneer (UGent) , Celine Jacobs (UGent) and Sylvie Rottey (UGent)

(2020) ACTA CLINICA BELGICA. 75(1). p.49-56
Add to list
Safety, tolerability, and potential clinical activity of a glucocorticoid-induced TNF receptor-related protein agonist alone or in combination with nivolumab for patients with advanced solid tumors : a phase 1/2a dose-escalation and cohort-expansion clinical trial

Kimberley M Heinhuis, Matteo Carlino, Markus Joerger, Massimo Di Nicola, Tarek Meniawy, Sylvie Rottey (UGent) , Victor Moreno, Anas Gazzah, Jean-Pierre Delord, Luis Paz-Ares, et al.

(2020) JAMA ONCOLOGY. 6(1). p.100-107
Add to list
- Journal Article
- A1
- open access
On-target pharmacodynamic activity of the PI3K inhibitor copanlisib in paired biopsies from patients with malignant lymphoma and advanced solid tumors

Franck Morschhauser, Jean-Pascal Machiels, Gilles Salles, Sylvie Rottey (UGent) , Simon A. J. Rule, David Cunningham, Frederic Peyrade, Christophe Fruchart, Hendrik-Tobias Arkenau, Isabelle Genvresse, et al.

(2020) MOLECULAR CANCER THERAPEUTICS. 19(2). p.468-478
Add to list
- Conference Paper
- C3
- open access
Drug development from bench to bedside @UZGENT

Johan Vande Walle (UGent) , Sylvie Rottey (UGent) and Bram De Wilde (UGent)

(2020) Drug Development from Bench to Bedside @UZGENT, Abstracts.
Add to list
- Journal Article
- A1
- open access
Radiologic extranodal extension and outcome in cN + D TNM-8 stage I human papillomavirus-mediated oropharyngeal cancer : in regard to Billfalk-Kelly et al.

Fréderic Duprez (UGent) , David Creytens (UGent) , Wilfried De Neve (UGent) , Philippe Deron (UGent) , Wouter Huvenne (UGent) , Sylvie Rottey (UGent) and Peter Tomassen (UGent)

(2020) INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 106(2). p.449-450
Add to list
- Miscellaneous
- open access
Congress highlights – ASCO 2019 special edition: Highlights in genitourinary cancers

Tijl Vermassen (UGent) and Sylvie Rottey (UGent)

(2019) Belgian Journal of Medical Oncology. 13(5). p.166-172

1
2
3
4
…
16
17

Next →